SCHEMBL6674510

SCHEMBL6674510

CC(C)(C)c1cc(COC(=O)CS)cc(C(C)(C)C)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
KMT2A Q03164 4/20 0.45
TSHR P16473 3/20 0.45
MAPK1 P28482 3/20 0.45
MEN1 O00255 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
BLM P54132 2/20 0.45
ATM Q13315 2/20 0.45
HIF1A Q16665 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPT P10636 2/20 0.45
USP2 O75604 1/20 0.45
CYP2D6 P10635 1/20 0.45
GAA P10253 6/20 0.45
LMNA P02545 3/20 0.45
TDP1 Q9NUW8 1/20 0.44
GMNN O75496 1/20 0.44
GABBR2 O75899 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125768 0.87 GAA (0.50) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL6696308 0.85 ALDH1A1 (0.46) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL11771112 0.84 VCAM1 (0.48) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL9015722 0.83 GAA (0.47) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL3125775 0.83 GAA (0.47) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL931514 0.81 ALDH1A1 (0.51) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL6403664 0.81 ALDH1A1 (0.49) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL6403668 0.81 GAA (0.53) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL784927 0.80 ALDH1A1 (0.46) ALDH1A1KMT2ATSHRMAPK1MEN1
SCHEMBL9015714 0.80 GAA (0.44) ALDH1A1KMT2ATSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004043443-A2 DRUGS FOR SEXUAL DYSFUNCTIONS NICOX S.A. (FR) 2004-05-27 WO claimed
CN-1420891-A Pharmaceutical compounds NICOX SA (FR) 2003-05-28 CN claimed
CN-1354740-A Pharmaceutical compounds NICOX SA (FR) 2002-06-19 CN claimed
US-4020042-A Phenolic antioxidants THE GOODYEAR TIRE & RUBBER COMPANY (US) 1977-04-26 US claimed
CN-119731255-A Use of additives for improving the processing of polyethylene 巴斯夫欧洲公司 2025-03-28 CN disclosed
CN-113348205-B Method for stabilizing halogen-free thermoplastic recyclates, plastic compositions, stabilizer compositions and use of stabilizer compositions 弗劳恩霍夫应用研究促进协会 2024-02-27 CN disclosed
CN-117413025-A Phosphite compositions 住友化学株式会社 2024-01-16 CN disclosed
CN-117242116-A Triazinyl ultraviolet absorbing polymers 巴斯夫欧洲公司 2023-12-15 CN disclosed
CN-117203272-A Stabilizer mixture 巴斯夫欧洲公司 2023-12-08 CN disclosed
CN-116583559-A Organic material-based molded article 巴斯夫欧洲公司 2023-08-11 CN disclosed
CN-116547346-A Additive mixture 巴斯夫欧洲公司 2023-08-04 CN disclosed
CN-116519627-A Method for detecting content of each component in polymer material auxiliary agent mixture by near infrared method 利安隆(珠海)新材料有限公司 2023-08-01 CN disclosed
WO-2004043443-A2 DRUGS FOR SEXUAL DYSFUNCTIONS NICOX S.A. (FR) 2004-05-27 WO disclosed
US-20040071777-A1 Solid dispersions of nitrate active principles NICOX S.A. (FR) 2004-04-15 US disclosed
WO-2003095471-A2 DEOXYCHOLIC ACID DERIVATIVES FOR THE TREATMENT OF ACUTE DYSFUNCTIONS OF PORTAL AND HEPATIC VENOUS CIRCULATION NICOX S.A. (IT) 2003-11-20 WO disclosed
CN-1420891-A Pharmaceutical compounds NICOX SA (FR) 2003-05-28 CN disclosed
CN-1354740-A Pharmaceutical compounds NICOX SA (FR) 2002-06-19 CN disclosed
US-5110978-A PROCESS FOR THE PREPARATION OF PHENOLIC THIOCARBOXYLIC ACID ESTERS CIBA-GEIGY CORPORATION (US) 1992-05-05 US disclosed
EP-0345221-A2 Polyamines partially substituted by piperidine-triazines CIBA-GEIGY AG (CH) 1989-12-06 EP disclosed
US-4020042-A Phenolic antioxidants THE GOODYEAR TIRE & RUBBER COMPANY (US) 1977-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040071777-A1 Solid dispersions of nitrate active principles PGD, NOS3, SORD ALDH1A1 2804/4885KMT2A 3728/4885TSHR 4221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.